(KRN) Krones - Ratings and Ratios
Filling Machines, Packaging Lines, PET Recycling, Process Technology
Dividends
| Dividend Yield | 1.99% |
| Yield on Cost 5y | 4.54% |
| Yield CAGR 5y | 30.87% |
| Payout Consistency | 80.8% |
| Payout Ratio | 28.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 23.9% |
| Value at Risk 5%th | 35.5% |
| Relative Tail Risk | -9.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | 3.43 |
| CAGR/Max DD | 0.41 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.548 |
| Beta | 0.442 |
| Beta Downside | 0.594 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.91% |
| Mean DD | 6.91% |
| Median DD | 5.94% |
Description: KRN Krones November 07, 2025
Krones AG (XETRA:KRN) designs, builds and services integrated production, filling and packaging lines for food- and beverage-manufacturers worldwide, operating through three divisions: Filling & Packaging Technology, Process Technology, and Intralogistics. The company’s equipment spans stretch-blow molding, capping, inspection, labeling, palletising and recycling of PET, as well as brew- and dairy-processing plants, water-treatment modules, and fully automated warehouse and AGV systems.
In FY 2023 Krones generated €5.3 billion of revenue with an adjusted EBIT margin of roughly 8 %, and its order backlog stood at about €2 billion-equivalent to 38 % of annual sales-indicating solid demand continuity. Key economic drivers include the secular rise in global beverage volumes (≈3 % CAGR), tightening sustainability regulations that boost demand for recyclable PET solutions, and the ongoing shift toward digital-enabled, high-speed intralogistics in the food-service sector. A material-cost exposure of ~30 % to steel and electronics makes the firm sensitive to commodity price swings, while its diversified client base (breweries, soft-drink makers, dairy, pharma, cosmetics) provides partial insulation from sector-specific downturns.
For a deeper, data-rich assessment of Krones’ valuation dynamics and scenario analysis, you may find the ValueRay platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (289.6m TTM) > 0 and > 6% of Revenue (6% = 331.6m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -2.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 16.45% (prev 15.18%; Δ 1.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 399.3m > Net Income 289.6m (YES >=105%, WARN >=100%) |
| Net Debt (-305.9m) to EBITDA (462.2m) ratio: -0.66 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (31.6m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 52.35% (prev 34.03%; Δ 18.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 118.2% (prev 113.1%; Δ 5.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 22.29 (EBITDA TTM 462.2m / Interest Expense TTM 14.7m) >= 6 (WARN >= 3) |
Altman Z'' 3.40
| (A) 0.19 = (Total Current Assets 3.25b - Total Current Liabilities 2.34b) / Total Assets 4.82b |
| (B) 0.32 = Retained Earnings (Balance) 1.52b / Total Assets 4.82b |
| (C) 0.07 = EBIT TTM 328.6m / Avg Total Assets 4.68b |
| (D) 0.64 = Book Value of Equity 1.78b / Total Liabilities 2.79b |
| Total Rating: 3.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.41
| 1. Piotroski 6.0pt |
| 2. FCF Yield 5.30% |
| 3. FCF Margin 3.71% |
| 4. Debt/Equity 0.07 |
| 5. Debt/Ebitda -0.66 |
| 6. ROIC - WACC (= 40.12)% |
| 7. RoE 14.66% |
| 8. Rev. Trend 94.42% |
| 9. EPS Trend 80.52% |
What is the price of KRN shares?
Over the past week, the price has changed by +3.65%, over one month by +2.35%, over three months by -2.39% and over the past year by +12.74%.
Is KRN a buy, sell or hold?
What are the forecasts/targets for the KRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 153.8 | 17.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 144 | 10.3% |
KRN Fundamental Data Overview November 26, 2025
Market Cap EUR = 4.09b (4.09b EUR * 1.0 EUR.EUR)
P/E Trailing = 14.133
P/E Forward = 21.0084
P/S = 0.7327
P/B = 1.9813
P/EG = 2.4
Beta = 0.961
Revenue TTM = 5.53b EUR
EBIT TTM = 328.6m EUR
EBITDA TTM = 462.2m EUR
Long Term Debt = 300.0k EUR (from longTermDebt, last quarter)
Short Term Debt = 1.30m EUR (from shortLongTermDebt, last quarter)
Debt = 136.6m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -305.9m EUR (from netDebt column, last fiscal year)
Enterprise Value = 3.87b EUR (4.09b + Debt 136.6m - CCE 362.8m)
Interest Coverage Ratio = 22.29 (Ebit TTM 328.6m / Interest Expense TTM 14.7m)
FCF Yield = 5.30% (FCF TTM 205.1m / Enterprise Value 3.87b)
FCF Margin = 3.71% (FCF TTM 205.1m / Revenue TTM 5.53b)
Net Margin = 5.24% (Net Income TTM 289.6m / Revenue TTM 5.53b)
Gross Margin = 52.35% ((Revenue TTM 5.53b - Cost of Revenue TTM 2.63b) / Revenue TTM)
Gross Margin QoQ = 52.97% (prev 54.74%)
Tobins Q-Ratio = 0.80 (Enterprise Value 3.87b / Total Assets 4.82b)
Interest Expense / Debt = 10.79% (Interest Expense 14.7m / Debt 136.6m)
Taxrate = 29.86% (28.9m / 96.8m)
NOPAT = 230.5m (EBIT 328.6m * (1 - 29.86%))
Current Ratio = 1.39 (Total Current Assets 3.25b / Total Current Liabilities 2.34b)
Debt / Equity = 0.07 (Debt 136.6m / totalStockholderEquity, last quarter 2.03b)
Debt / EBITDA = -0.66 (Net Debt -305.9m / EBITDA 462.2m)
Debt / FCF = -1.49 (Net Debt -305.9m / FCF TTM 205.1m)
Total Stockholder Equity = 1.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.01% (Net Income 289.6m / Total Assets 4.82b)
RoE = 14.66% (Net Income TTM 289.6m / Total Stockholder Equity 1.98b)
RoCE = 16.63% (EBIT 328.6m / Capital Employed (Equity 1.98b + L.T.Debt 300.0k))
RoIC = 47.76% (NOPAT 230.5m / Invested Capital 482.5m)
WACC = 7.64% (E(4.09b)/V(4.23b) * Re(7.64%) + D(136.6m)/V(4.23b) * Rd(10.79%) * (1-Tc(0.30)))
Discount Rate = 7.64% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 74.13% ; FCFE base≈246.8m ; Y1≈192.9m ; Y5≈125.0m
Fair Price DCF = 73.94 (DCF Value 2.34b / Shares Outstanding 31.6m; 5y FCF grow -26.03% → 3.0% )
EPS Correlation: 80.52 | EPS CAGR: 6.13% | SUE: -0.32 | # QB: 0
Revenue Correlation: 94.42 | Revenue CAGR: 8.78% | SUE: -0.30 | # QB: 0
EPS current Year (2025-12-31): EPS=9.92 | Chg30d=-0.011 | Revisions Net=-2 | Growth EPS=+13.1% | Growth Revenue=+7.5%
EPS next Year (2026-12-31): EPS=10.76 | Chg30d=-0.078 | Revisions Net=-2 | Growth EPS=+8.5% | Growth Revenue=+4.7%